Lorcaserin Extended-Release Tablets and PegIntron
Determining the interaction of Lorcaserin Extended-Release Tablets and PegIntron and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: Pegintron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Pegloticase
- Lorcaserin Extended-Release Tablets-Pegloticase Intravenous
- Lorcaserin Extended-Release Tablets-Pegvaliase
- Lorcaserin Extended-Release Tablets-Pegvaliase-pqpz
- Lorcaserin Extended-Release Tablets-Pegvaliase-pqpz Subcutaneous
- Lorcaserin Extended-Release Tablets-Pegvisomant
- PegIntron-Lorcaserin Hydrochloride
- PegIntron-Lorcaserin Tablets
- PegIntron-Lorcet
- PegIntron-Lorcet Plus
- PegIntron-Lorcet Tablets
- PegIntron-Lorlatinib